<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations - Nejstgaard, CH - 2020 | Cochrane Library</title> <meta content="Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations - Nejstgaard, CH - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000040.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations - Nejstgaard, CH - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000040.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.MR000040.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations" name="citation_title"/> <meta content="Camilla Hansen Nejstgaard" name="citation_author"/> <meta content="camilla.hansen3@rsyd.dk" name="citation_author_email"/> <meta content="Lisa Bero" name="citation_author"/> <meta content="University of Colorado" name="citation_author_institution"/> <meta content="Asbjørn Hróbjartsson" name="citation_author"/> <meta content="Anders W Jørgensen" name="citation_author"/> <meta content="ENT Clinic Hobro" name="citation_author_institution"/> <meta content="Karsten Juhl Jørgensen" name="citation_author"/> <meta content="Rigshospitalet" name="citation_author_institution"/> <meta content="Mary Le" name="citation_author"/> <meta content="Stasjonsgata Legekontor" name="citation_author_institution"/> <meta content="Andreas Lundh" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.MR000040.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/12/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000040.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000040.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000040.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Advisory Committees [*ethics, statistics &amp; numerical data]; Authorship; Bias; *Conflict of Interest [economics]; Consultants; Datasets as Topic [*ethics, statistics &amp; numerical data]; Drug Industry [ethics]; Editorial Policies; Equipment and Supplies [ethics]; *Practice Guidelines as Topic; Publications [*ethics]; Radiologists; Review Literature as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000040.pub3&amp;doi=10.1002/14651858.MR000040.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eMR000040\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eMR000040\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","pt","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.MR000040.pub3",title:"Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations",firstPublishedDate:"Dec 8, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Methodology Review Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000040.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000040.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.MR000040.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.MR000040.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000040.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="MR000040.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.MR000040.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="MR000040.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.MR000040.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.MR000040.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2945 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.MR000040.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0048"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0011"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0013"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0036"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-sec-0042"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/appendices#MR000040-sec-0053"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/table_n/MR000040StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/table_n/MR000040StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Methodology</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Camilla Hansen Nejstgaard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0005">Lisa Bero</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0006">Asbjørn Hróbjartsson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0007">Anders W Jørgensen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0008">Karsten Juhl Jørgensen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0009">Mary Le</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information#MR000040-cr-0010">Andreas Lundh</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information/en#MR000040-sec-0065">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 December 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.MR000040.pub3">https://doi.org/10.1002/14651858.MR000040.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="MR000040-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000040-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000040-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000040-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000040-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000040-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000040-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="MR000040-abs-0001" lang="en"> <section id="MR000040-sec-0001"> <h3 class="title" id="MR000040-sec-0001">Background</h3> <p>Treatment and diagnostic recommendations are often made in clinical guidelines, reports from advisory committee meetings, opinion pieces such as editorials, and narrative reviews. Quite often, the authors or members of advisory committees have industry ties or particular specialty interests which may impact on which interventions are recommended. Similarly, clinical guidelines and narrative reviews may be funded by industry sources resulting in conflicts of interest. </p> </section> <section id="MR000040-sec-0002"> <h3 class="title" id="MR000040-sec-0002">Objectives</h3> <p>To investigate to what degree financial and non‐financial conflicts of interest are associated with favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. </p> </section> <section id="MR000040-sec-0003"> <h3 class="title" id="MR000040-sec-0003">Search methods</h3> <p>We searched PubMed, Embase, and the Cochrane Methodology Register for studies published up to February 2020. We also searched reference lists of included studies, Web of Science for studies citing the included studies, and grey literature sources. </p> </section> <section id="MR000040-sec-0004"> <h3 class="title" id="MR000040-sec-0004">Selection criteria</h3> <p>We included studies comparing the association between conflicts of interest and favourable recommendations of drugs or devices (e.g. recommending a particular drug) in clinical guidelines, advisory committee reports, opinion pieces, or narrative reviews. </p> </section> <section id="MR000040-sec-0005"> <h3 class="title" id="MR000040-sec-0005">Data collection and analysis</h3> <p>Two review authors independently included studies, extracted data, and assessed risk of bias. When a meta‐analysis was considered meaningful to synthesise our findings, we used random‐effects models to estimate risk ratios (RRs) with 95% confidence intervals (CIs), with RR &gt; 1 indicating that documents (e.g. clinical guidelines) with conflicts of interest more often had favourable recommendations. We analysed associations for financial and non‐financial conflicts of interest separately, and analysed the four types of documents both separately (pre‐planned analyses) and combined (post hoc analysis). </p> </section> <section id="MR000040-sec-0006"> <h3 class="title" id="MR000040-sec-0006">Main results</h3> <p>We included 21 studies analysing 106 clinical guidelines, 1809 advisory committee reports, 340 opinion pieces, and 497 narrative reviews. We received unpublished data from 11 studies; eight full data sets and three summary data sets. Fifteen studies had a risk of confounding, as they compared documents that may differ in other aspects than conflicts of interest (e.g. documents on different drugs used for different populations). The associations between financial conflicts of interest and favourable recommendations were: clinical guidelines, RR: 1.26, 95% CI: 0.93 to 1.69 (four studies of 86 clinical guidelines); advisory committee reports, RR: 1.20, 95% CI: 0.99 to 1.45 (four studies of 629 advisory committee reports); opinion pieces, RR: 2.62, 95% CI: 0.91 to 7.55 (four studies of 284 opinion pieces); and narrative reviews, RR: 1.20, 95% CI: 0.97 to 1.49 (four studies of 457 narrative reviews). An analysis combining all four document types supported these findings (RR: 1.26, 95% CI: 1.09 to 1.44). </p> <p>One study investigating specialty interests found that the association between including radiologist guideline authors and recommending routine breast cancer screening was RR: 2.10, 95% CI: 0.92 to 4.77 (12 clinical guidelines). </p> </section> <section id="MR000040-sec-0007"> <h3 class="title" id="MR000040-sec-0007">Authors' conclusions</h3> <p>We interpret our findings to indicate that financial conflicts of interest are associated with favourable recommendations of drugs and devices in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. However, we also stress risk of confounding in the included studies and the statistical imprecision of individual analyses of each document type. It is not certain whether non‐financial conflicts of interest impact on recommendations. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="MR000040-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000040-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000040-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000040-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000040-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#MR000040-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000040-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#MR000040-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#MR000040-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="MR000040-abs-0002" lang="en"> <h3>Conflicts of interest and recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews </h3> <p>Which treatments and diagnostic tests doctors offer to their patients are often based on recommendations expressed in a variety of documents. A common example is clinical guidelines, which are statements providing recommendations on how to diagnose and treat patients on the basis of the best available evidence. The treatments that may be offered to patients are also influenced by which drugs are recommended for approval by drug advisory committees at regulatory drug agencies such as the US Food and Drug Administration (FDA). Finally, doctors may also be influenced by recommendations expressed in opinion pieces, such as editorials, or in narrative review papers in medical journals. </p> <p>Quite often, publications expressing clinical recommendations are written by authors with conflicts of interest related to a specific product, for example when the author acts as a consultant for the company producing the treatment of interest. Such conflicts of interest may impact on the recommendations made. Similarly, authors may have so‐called non‐financial conflicts of interest such as belonging to a specific profession, for example being an orthopaedic surgeon, which may influence whether a specific intervention is preferred over another. This Cochrane Methodology Review investigated how financial and non‐financial conflicts of interest are associated with the recommendations made in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. </p> <p>We included 21 studies and we interpreted our findings to indicate that financial conflicts of interest are associated with favourable recommendations in these documents, although there is some uncertainty around the size of the effect. This means that when such publications are written by authors with financial conflicts of interest, they more often have favourable recommendations than publications written by authors without conflicts of interest. Only a single study investigated the impact of non‐financial conflicts of interest in clinical guidelines and the results were uncertain, but indicated a similar direction of effect. </p> <p>We suggest that patients, doctors, and healthcare decision makers primarily use clinical guidelines, opinion pieces, and narrative reviews that have been written by authors without financial conflicts of interest. If that is not possible, users should read and interpret the publications with caution. Furthermore, our findings suggest that if committee members are asked to vote on the recommendation of a drug, they may be more likely to vote in favour of the drug when they have financial conflicts of interest. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="MR000040-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="MR000040-sec-0048"></div> <h3 class="title" id="MR000040-sec-0049">Implication for systematic reviews and evaluations of healthcare</h3> <section id="MR000040-sec-0049"> <p>We interpreted our findings to indicate that financial conflicts of interest are associated with favourable recommendations of drugs and devices in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. Although the magnitude of effect is fairly consistent across document types, most studies had a risk of confounding and our individual analyses of each document type had some degree of statistical imprecision. It is more uncertain whether non‐financial conflicts of interest impact on recommendations. </p> <p>Our findings support conflicts of interest policies from major guideline issuing organisations such as the National Institute for Health and Care Excellence, the US Preventive Services Task Force, and the World Health Organization (<a href="./references#MR000040-bbs2-0160" title="National Institute for Health and Care Excellence (NICE). Policy on declaring and managing interests for NICE advisory committees. https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaration-of-interests-policy.pdf (accessed 18 December 2019).">NICE 2019</a>; <a href="./references#MR000040-bbs2-0167" title="US Preventive Services Task Force. Conflict of Interest Disclosures. https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures (accessed 31 Jan 2018).">U.S. Preventive Services Task Force 2018</a>; <a href="./references#MR000040-bbs2-0169" title="WHO. Handbook for Guideline Development. https://apps.who.int/iris/handle/10665/145714 (accessed 9 November 2020).">WHO 2014</a>). These policies aim to minimise the number and role of guideline authors with conflicts of interest. Similarly, some high impact journals manage conflicts of interest beyond disclosure, for example <i>New England Journal of Medicine</i> prohibits narrative reviews and editorials with significant financial conflicts of interest (&gt; US$ 10,000), and <i>The Lancet</i> prohibits commentaries, seminars, reviews, and series by authors with relevant stock ownership, employment, or company board membership (<a href="./references#MR000040-bbs2-0138" title="BeroL . More journals should have conflict of interest policies as strict as Cochrane. BMJ Opinion2018.">Bero 2018</a>; <a href="./references#MR000040-bbs2-0159" title="LundhA , RasmussenK , ØstengaardL , BoutronI , StewartLA , HróbjartssonA . Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially. Journal of Clinical Epidemiology2020;120:104-15.">Lundh 2020</a>). Other journals should consider introducing such polices in order to minimise the influence from conflicts of interest on journal content. </p> <p>In line with this, the FDA introduced more stringent criteria on which types of conflicts of interest where allowed for committee members in 2008 (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>). This could be a possible explanation as to why the study by Zhang and colleagues (<a href="./references#MR000040-bbs2-0021" title="ZhangAD , SchwartzJL , RossJS . Association between Food and Drug Administration advisory committee recommendations and agency actions, 2008-2015. Milbank Quarterly2019;97(3):796-819. ">Zhang 2019</a>), which exclusively sampled advisory committee reports from 2008 and onwards, found a somewhat weaker association between financial conflicts of interest and recommendations in advisory committee reports than the three other studies included in our pooled analyses (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>; <a href="./references#MR000040-bbs2-0018" title="TibauA , OcanaA , AngueraG , SerugaB , TempletonAJ , BarnadasA , et al. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration. JAMA Oncology2016;2(6):744-50. ">Tibau 2016</a>). </p> <p>To minimise influence from conflicts of interest we suggest that patients, clinicians, and healthcare decision makers primarily use clinical guidelines that are based on rigorous methodology and have clear policies of how to manage conflicts of interest, such as excluding or minimising the role of members with conflicts and ensuring a broad skill set in the panel. If such guidelines are not available, users should interpret such guidelines with caution. Similarly, journal readers should prefer publications written by authors without conflicts of interest. </p> </section> <h3 class="title" id="MR000040-sec-0050">Implication for methodological research</h3> <section id="MR000040-sec-0050"> <p>Ideally, future studies should try to minimise the risk of confounding, e.g. by using a matched study design (<a href="./references#MR000040-bbs2-0155" title="JørgensenAW , HildenJ , GøtzschePC . Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ2006;333(7572):782.">Jørgensen 2006</a>). However, identifying editorials commenting on the same study or guidelines addressing the same question and developed using similar methods might be a challenge. Furthermore, future research could focus on investigating whether specific types of financial conflicts of interest (e.g. advisory board membership) or conflicts of interest related to specific companies (e.g. drug manufacturer) have a greater impact than others. Moreover, the included studies used various definitions of financial conflicts of interest and recommendations, and use of a standardised terminology would be helpful. </p> <p>Investigating the impact of non‐financial conflicts of interest is challenging because no uniform definition exists. On one hand, a multitude of interests such as specialty interests, intellectual interests, personal beliefs, and personal relationships can be viewed as non‐financial conflicts of interest (<a href="./references#MR000040-bbs2-0165" title="The PLoS Medicine Editors. Making sense of non-financial competing interests. PLOS Medicine2008;5(9):e199.">The PLoS Medicine Editors 2008</a>; <a href="./references#MR000040-bbs2-0168" title="ViswanathanM , CareyTS , BelinsonSE , BerlinerE , ChangSM , GrahamE , et al. A proposed approach may help systematic reviews retain needed expertise while minimizing bias from nonfinancial conflicts of interest. Journal of Clinical Epidemiology2014;67(11):1229-38.">Viswanathan 2014</a>). On the other hand, labelling personal beliefs and theoretical schools of thoughts as conflicts of interest risks muddying the waters since no researcher is completely interest free or free from intellectual pre‐conceptions (<a href="./references#MR000040-bbs2-0040" title="BeroL . What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. Journal of Clinical Epidemiology2014;67(11):1239-41. ">Bero 2014</a>; <a href="./references#MR000040-bbs2-0136" title="BeroLA , GrundyQ . Why Having a (nonfinancial) interest is not a conflict of interest. PLOS Biology2016;14(12):e2001221.">Bero 2016</a>; <a href="./references#MR000040-bbs2-0137" title="BeroL . Addressing bias and conflict of interest among biomedical researchers. JAMA2017;317(17):1723-4.">Bero 2017</a>). Furthermore, the distinction between financial and non‐financial conflicts of interest is not always clear. For example, in relation to the included study on mammography screening guidelines (<a href="./references#MR000040-bbs2-0012" title="NorrisSL , BurdaBU , HolmerHK , OgdenLA , FuR , BeroL , et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology2012;65(7):725-33. ">Norris 2012</a>), it can be debated whether being a radiologist should be considered a purely non‐financial conflict of interest because radiologists may have direct financial income from breast cancer screening. Future studies could focus on investigating the impact of the various types of non‐financial conflicts of interest on favourable recommendations and on the impact of managing such interests using guideline panels with a broad range of skill sets, rather than mainly content area experts. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="MR000040-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="MR000040-sec-0008"></div> <p>Recommendations of treatment and diagnostic approaches impact on patient care, especially if they are written by “key opinion leaders” or originate from healthcare authorities. Recommendations may appear in multiple types of documents, for example in clinical guidelines and advisory committee reports (which could include records from meetings in regulatory drug advisory committees or hospital drug and therapeutics committees) as well as in opinion pieces such as editorials, and in narrative reviews. </p> <p>Quite often, publications with clinical recommendations are written by authors with conflicts of interest related to the drug or device industry. For example, in a sample of 45 clinical guidelines written by 254 authors, Bindslev and colleagues found that 135 (53%) authors had financial conflicts of interest (<a href="./references#MR000040-bbs2-0042" title="BindslevJB , SchrollJ , GøtzschePC , LundhA . Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Medical Ethics2013;14:19. ">Bindslev 2013</a>). Similarly, studies report that narrative reviews, editorials and commentaries often (31%) had at least one author with conflicts of interest (<a href="./references#MR000040-bbs2-0146" title="GrundyQ , DunnAG , BourgeoisFT , CoieraE , BeroL . Prevalence of disclosed conflicts of interest in biomedical research and associations with journal impact factors and altmetric scores. JAMA2018;319(4):408-9.">Grundy 2018</a>), and around a quarter of committee meetings at the US Food and Drug Administration (FDA) included at least one voting member with financial conflicts of interest (<a href="./references#MR000040-bbs2-0020" title="XuJ , EmenanjoO , OrtwerthM , LurieP . Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings-a cross-sectional study. JAMA Internal Medicine2017;177(7):1038-40. ">Xu 2017</a>). </p> <p>Authors may also have non‐financial conflicts of interest. For example, if authors of a guideline were also authors of some of the included studies on which recommendations in a guideline were based, the authors may be more likely to favour the interventions that they previously studied (<a href="./references#MR000040-bbs2-0025" title="AklEA , El-HachemP , Abou-HaidarH , NeumannI , SchünemannHJ , GuyattGH . Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study. Journal of Clinical Epidemiology2014;67(11):1222-8. ">Akl 2014</a>). Whereas financial conflicts of interest are relatively simple to characterise (i.e. any financial relationship with a party with an interest in the direction of a recommendation), it is more unclear and debated which interests and relationships constitute a non‐financial conflict of interest and whether the term is appropriate (<a href="./references#MR000040-bbs2-0136" title="BeroLA , GrundyQ . Why Having a (nonfinancial) interest is not a conflict of interest. PLOS Biology2016;14(12):e2001221.">Bero 2016</a>). This lack of consensus regarding non‐financial conflicts of interest is also reflected in journal disclosure policies. Shawwa and colleagues found that only 57% of core clinical journals specifically required disclosure of non‐financial conflicts of interest, and that there was large variation in how journals defined such conflicts (<a href="./references#MR000040-bbs2-0164" title="ShawwaK , KallasR , KoujanianS , AgarwalA , NeumannI , AlexanderP , et al. Requirements of clinical journals for authors' disclosure of financial and non-financial conflicts of interest: a cross sectional study. PLOS One2016;11(3):e0152301.">Shawwa 2016</a>). </p> <p>Numerous studies have investigated the impact of financial conflicts of interest on the interpretation of the results of primary research studies, mainly clinical trials. An updated Cochrane Methodology Review reported an association between industry funding and favourable conclusions in primary research studies (<a href="./references#MR000040-bbs2-0158" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>). This association has been attributed to various factors, including the sponsor's influence on framing the question, study design, and reporting of results (<a href="./references#MR000040-bbs2-0134" title="BeroLA , RennieD . Influences on the quality of published drug studies. International Journal of Technology Assessment in Health Care1996;12(2):209-37.">Bero 1996</a>; <a href="./references#MR000040-bbs2-0135" title="BeroL , OostvogelF , BacchettiP , LeeK . Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLOS Medicine2007;4(6):e184.">Bero 2007</a>; <a href="./references#MR000040-bbs2-0143" title="FabbriA , LaiA , GrundyQ , BeroLA . The influence of industry sponsorship on the research agenda: a scoping review. American Journal of Public Health2018;108(11):e9-e16.">Fabbri 2018</a>). Similarly, another Cochrane Methodology Review reported an association between financial conflicts of interest and favourable conclusions in systematic reviews (<a href="./references#MR000040-bbs2-0149" title="HansenC , LundhA , RasmussenK , HróbjartssonA . Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews2019, Issue 8. Art. No: MR000047. [DOI: 10.1002/14651858.MR000047.pub2]">Hansen 2019a</a>). In contrast, few studies have investigated the association between conflicts of interest and favourable recommendations in clinical guidelines (<a href="./references#MR000040-bbs2-0012" title="NorrisSL , BurdaBU , HolmerHK , OgdenLA , FuR , BeroL , et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology2012;65(7):725-33. ">Norris 2012</a>), advisory committee reports (<a href="./references#MR000040-bbs2-0014" title="Pham-KanterG . Revisiting financial conflicts of interest in FDA advisory committees. Milbank Quarterly2014;92(3):446-70. ">Pham‐Kanter 2014</a>), opinion pieces (<a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>), and narrative reviews (<a href="./references#MR000040-bbs2-0006" title="DunnAG , ZhouX , HudginsJ , ArachiD , MandlKD , CoieraE , et al. Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors. Journal of Clinical Epidemiology2016;80:43-9. ">Dunn 2016</a>). Furthermore, the evidence from such studies has to our knowledge not previously been synthesised in a methodological systematic review. This review fills that gap and is based on the previously published protocol (<a href="./references#MR000040-bbs2-0170" title="HansenC , BeroL , HróbjartssonA , JørgensenAW , JørgensenKJ , LeM , et al. Conflicts of interest and recommendations in clinical guidelines, opinion pieces, and narrative reviews. Cochrane Database of Systematic Reviews2019, Issue 10. Art. No: MR000040. [DOI: 10.1002/14651858.MR000040.pub2]">Hansen 2019b</a>). </p> <section id="MR000040-sec-0009"> <h3 class="title" id="MR000040-sec-0009">How these methods might work</h3> <p>Financial conflicts of interest such as honoraria, consultancies, grants, or advisory board membership can provide a substantial income for physicians and academic researchers. Such relationships may therefore affect how the benefits and harms of the companies' products are perceived by authors and thereby whether they are recommended in publications by the authors. Similarly, non‐financial interests, such as authors’ professional affiliations and personal relationships, may influence the recommendation of a particular intervention. </p> <p>In contrast to primary research papers and systematic reviews, clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews typically provide specific recommendations concerning treatments and diagnostics. However, the methodological rigour behind such recommendations differs between the types of publications. Clinical guidelines are increasingly based on systematic searches of existing evidence and may follow standardised procedures for grading evidence and recommendations (<a href="./references#MR000040-bbs2-0148" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011</a>). In contrast, authors of opinion pieces are free to selectively cite studies and interpret the evidence, and editorials often focus on results from a single primary study. Clinical guidelines are also typically written by a broad group of authors who may have differing viewpoints, whereas opinion pieces are often written by single authors. Thus, clinical guidelines may be less susceptible to influence from conflicts of interest compared to opinion pieces. Committee reports and narrative reviews are conducted using more or less systematic procedures, but also involve subjective elements and may therefore be more susceptible to influence from conflicts of interest than clinical guidelines, but less than opinion pieces. </p> </section> <section id="MR000040-sec-0010"> <h3 class="title" id="MR000040-sec-0010">Why it is important to do this review</h3> <p>Recommendations in journal papers or guidelines and decisions about which interventions are approved by regulatory authorities have substantial impact on the interventions offered to patients. It is therefore important that such recommendations are evidence‐based and as little influenced by conflicts of interest as possible. Individual studies have investigated the associations between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews, but these studies differ in methods and conclusions. Despite conflicts of interest being recognised as an important source of influence on clinical recommendations, these studies have, to our knowledge, not previously been summarised in a systematic review. Findings from this review may provide patients, clinicians, and policymakers with guidance on how to interpret recommendations in light of conflicts of interest and may assist journal editors, guideline issuing organisations, and public authorities with managing such conflicts. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="MR000040-sec-0011" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="MR000040-sec-0011"></div> <p>Our objectives were to investigate to what degree financial and non‐financial conflicts of interests are associated with favourable recommendations in: </p> <p> <ul id="MR000040-list-0001"> <li> <p>clinical guidelines;</p> </li> <li> <p>advisory committee reports (e.g. records from the Food and Drug Administration (FDA) advisory committee on oncological drugs or hospital drug and therapeutics committees); </p> </li> <li> <p>opinion pieces (e.g. editorials and commentaries);</p> </li> <li> <p>narrative reviews.</p> </li> </ul> </p> <section id="MR000040-sec-0012"> <h3 class="title" id="MR000040-sec-0012">Terminology</h3> <p>We used the definitions below. All definitions are described in more detail in <a href="./appendices#MR000040-sec-0054">Appendix 1</a>. </p> <p>Conflicts of interest: any financial or non‐financial conflicts of interest as specified below. </p> <p>Financial conflicts of interest: any funding of clinical guidelines, opinion pieces, or narrative reviews by drug or device companies or any authors or committee members with ties to such companies (e.g. advisory board membership). </p> <p>Non‐financial conflicts of interest: any relationships that differ from what is typically regarded as financial conflicts of interest (i.e. relationships with the drug or device industry). Regardless of the definitions used by the authors of the included studies, we do not focus on studies investigating beliefs (e.g. political or religious), personal experience (e.g. abuse or trauma), or institutional conflicts of interest (<a href="./references#MR000040-bbs2-0136" title="BeroLA , GrundyQ . Why Having a (nonfinancial) interest is not a conflict of interest. PLOS Biology2016;14(12):e2001221.">Bero 2016</a>). </p> <p>Drugs: medications that require approval from a regulatory authority.</p> <p>Devices: instruments used in diagnosis, treatment, or prevention of disease (<a href="./references#MR000040-bbs2-0144" title="FDA. Medical Device Overview. https://www.fda.gov/ForIndustry/ImportProgram/ImportBasics/RegulatedProducts/ucm510630.htm. Last updated 12 Jan 2017 (accessed 25 Apr 2018).">FDA 2017</a>). This term also includes medical imaging technologies. </p> <p>Clinical guidelines: <i>“Systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances”</i> (<a href="./references#MR000040-bbs2-0152" title="Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines Field MJ, Lohr KN (editors). Clinical Practice Guidelines: Directions for a New Program. Washington (DC): National Academies Press (US), 1990.">Institute of Medicine 1990</a>). </p> <p>Advisory committee reports: reports from meetings held in committees, boards, councils, or similar formalised groups that are established to advise an organisation and provide a recommendation concerning an intervention (e.g. the FDA advisory committee on oncological drugs). </p> <p>Opinion pieces: publications that are not research studies in which an author expresses a personal opinion about a specific intervention (e.g. editorials, commentaries, and letters to the editor). </p> <p>Narrative reviews: literature reviews without a systematic search of the literature with clear eligibility criteria. </p> <p>Documents: clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="MR000040-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="MR000040-sec-0013"></div> <section id="MR000040-sec-0014"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="MR000040-sec-0015"> <h4 class="title">Types of studies</h4> <p>We included published and unpublished studies of any design (e.g. cross‐sectional studies) that assessed the association between conflicts of interest and favourable recommendations made in clinical guidelines, advisory committee reports, opinion pieces, or narrative reviews concerning drug or device interventions (which include diagnostic tests for the purposes of this review, see <a href="./appendices#MR000040-sec-0054">Appendix 1</a>). </p> <p>Studies in all languages were eligible.</p> </section> <section id="MR000040-sec-0016"> <h4 class="title">Types of data</h4> <p>We included studies with dichotomous (e.g. favourable or unfavourable recommendations) or continuous data (e.g. percentages) on the association between conflicts of interest and recommendations in favour of the intervention in question. </p> </section> <section id="MR000040-sec-0017"> <h4 class="title">Types of methods</h4> <p>We included studies that investigated documents with conflicts of interest versus documents without conflicts of interest. For financial conflicts of interest, we included studies regardless of the type of financial conflict. For non‐financial conflicts of interest, we included studies on intellectual, academic, professional, or specialty interests, and personal or professional relationships. </p> <p>We excluded studies concerning:</p> <p> <ul id="MR000040-list-0002"> <li> <p>financial conflicts of interest not related to the drug or device industry (e.g. tobacco or nutrition industry); </p> </li> <li> <p>beliefs (e.g. religious) or personal experiences (e.g. suffering from the medical condition), even if the original authors defined these as non‐financial conflicts of interest; </p> </li> <li> <p>membership of certain groups (e.g. gender or ethnicity), even if the original authors defined this as non‐financial conflicts of interest; </p> </li> <li> <p>both financial and non‐financial conflicts of interest at the level of an institution;</p> </li> <li> <p>conflicts of interest related to reports from scientific grant committees.</p> </li> </ul> </p> </section> <section id="MR000040-sec-0018"> <h4 class="title">Types of outcome measures</h4> <section id="MR000040-sec-0019"> <h5 class="title">Primary outcomes</h5> <p>Our primary outcome was the type of recommendation in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. We defined ‘favourable recommendations’ according to the definitions used by the authors of the included studies. </p> </section> </section> </section> <section id="MR000040-sec-0020"> <h3 class="title">Search methods for identification of studies</h3> <section id="MR000040-sec-0021"> <h4 class="title">Electronic searches</h4> <p>We searched PubMed, Embase, and the Cochrane Methodology Register (up to February 2020). We searched Web of Science (up to March 2020) for studies that cited any of the included studies. </p> <section id="MR000040-sec-0022"> <h5 class="title">Search strategy</h5> <p>Our search strategy was based on search terms used in a PubMed search from two previous Cochrane Methodology Reviews on financial conflicts of interest in primary research studies and systematic reviews (<a href="./references#MR000040-bbs2-0158" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>; <a href="./references#MR000040-bbs2-0149" title="HansenC , LundhA , RasmussenK , HróbjartssonA . Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews2019, Issue 8. Art. No: MR000047. [DOI: 10.1002/14651858.MR000047.pub2]">Hansen 2019a</a>), and tailored it for this review (<a href="./appendices#MR000040-sec-0055">Appendix 2</a>). The PubMed strategy was adapted for Embase and The Cochrane Methodology Register. All search strategies were developed in collaboration with information specialists. </p> </section> </section> <section id="MR000040-sec-0023"> <h4 class="title">Searching other resources</h4> <section id="MR000040-sec-0024"> <h5 class="title">Grey literature</h5> <p>Our electronic search in the Cochrane Methodology Register identified relevant grey literature because the database includes conference abstracts. Additionally, we searched for conference abstracts from Peer Review Congresses (<a href="./references#MR000040-bbs2-0132" title="American Medical Association. Eighth International Congress on Peer Review and Scientific Publication. http://www.peerreviewcongress.org/index.html (accessed 19 February 2020).">American Medical Association 2017</a>), Cochrane Colloquia (<a href="./references#MR000040-bbs2-0142" title="Cochrane Community. Colloquium. http://community.cochrane.org/news/events/colloquium (accessed 19 February 2020).">Cochrane Community 2017</a>), and Evidence Live (<a href="./references#MR000040-bbs2-0139" title="Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences. Evidence Live. http://evidencelive.org/ (accessed 19 February 2020).">Centre for Evidence‐Based Medicine 2017</a>) (search of all conferences up to February 2020). We searched PROSPERO (up to February 2020) for registered systematic reviews and the ProQuest database (up to February 2020) for dissertations and theses. </p> </section> <section id="MR000040-sec-0025"> <h5 class="title">Additional searches</h5> <p>We used Google Scholar (up to March 2020) to search for additional eligible studies. We based our search on core search terms from the search strategy defined in <a href="./appendices#MR000040-sec-0055">Appendix 2</a> and screened the first 20 records for each search. We searched PubMed for publications by the first and last author of the included studies (up to March 2020). Other sources of data included the files of the authors of this review and checking reference lists of included studies (<a href="./references#MR000040-bbs2-0151" title="HorsleyT , DingwallO , SampsonM . Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews2011, Issue 8. Art. No: MR000026. [DOI: 10.1002/14651858.MR000026.pub2]">Horsley 2011</a>). </p> </section> </section> </section> <section id="MR000040-sec-0026"> <h3 class="title" id="MR000040-sec-0026">Data collection and analysis</h3> <section id="MR000040-sec-0027"> <h4 class="title">Selection of studies</h4> <p>One review author (CHN) screened titles and abstracts of all retrieved records for obvious exclusions. Two review authors (CHN and either AWJ or AL) independently assessed potentially eligible studies based on full text. We resolved any disagreements by discussion and used arbitration by a third review author (AL or AH) when needed. </p> <p>Reasons for exclusion of studies are described in the '<a href="./references#MR000040-sec-0072" title="">Characteristics of excluded studies</a>' table. </p> </section> <section id="MR000040-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (CHN and either AWJ, ML, or AL) independently extracted data from included studies. We resolved any differences in data extraction by discussion and used arbitration by a third review author (AH or AL) when needed. </p> <p>We extracted data on basic characteristics of the included studies and data on the association between conflicts of interest and favourable recommendations. We extracted data for documents with and without conflicts of interest based on the definitions used by the authors of the included studies. When reported, we also extracted effect measures and confidence intervals (CIs) or the raw data to calculate them. We also extracted information on funding sources and conflicts of interest disclosures of authors of the included studies. The full plan for data extraction is reported in <a href="./appendices#MR000040-sec-0056">Appendix 3</a>. </p> </section> <section id="MR000040-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>As there are no published assessment tools for investigating bias in these types of studies, we developed our own criteria based on those used in previous Cochrane Methodology Reviews on financial conflicts of interest in primary research studies and systematic reviews (<a href="./references#MR000040-bbs2-0158" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>; <a href="./references#MR000040-bbs2-0149" title="HansenC , LundhA , RasmussenK , HróbjartssonA . Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews2019, Issue 8. Art. No: MR000047. [DOI: 10.1002/14651858.MR000047.pub2]">Hansen 2019a</a>). In accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000040-bbs2-0150" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>) we use the term ‘risk of bias’ in contrast to ‘methodological quality’. However, we recognise that some of the included items are more related to methodological quality than risk of bias and that inadequate methodological quality (e.g. coding of conflicts of interest information by a single author) is not necessarily biased. In our risk of bias assessment we therefore focused on whether study methodology was appropriate (i.e. appropriate methodology resulted in low risk of bias). </p> <p>Two review authors (CHN and either AWJ, ML, or AL) independently assessed included studies for risk of bias. We resolved any disagreements by discussion and used arbitration by a third review author (AL or AH) when needed. We used the following criteria. </p> <p> <ul id="MR000040-list-0003"> <li> <p>Whether there was a risk of bias in the inclusion of documents (low risk of bias may, for example, include reporting of clear inclusion criteria with two or more assessors independently selecting documents). </p> </li> <li> <p>Whether there was a risk of bias in the coding of conflicts of interest (low risk of bias may, for example, include coding done by two or more assessors based on multiple sources of information). </p> </li> <li> <p>Whether there was a risk of bias in the coding of recommendations (low risk of bias may, for example, include coding done by two or more assessors blinded to the status of conflicts of interest). </p> </li> <li> <p>Whether there was a risk of confounding (low risk of confounding may, for example, include documents with and without conflicts of interest discussing the same treatment used in similar groups of patients). The documents included in a study may differ on key aspects (e.g. in a sample of clinical guidelines, the guidelines may differ in relation to types of patients and conditions, interventions, the quality of the underlying evidence, and the quality of the guidelines), which could potentially confound the association between conflicts of interest and favourable recommendations. </p> </li> </ul> </p> <p>In assessing risk of bias, our primary aim was to differentiate between studies with higher and lower risk of bias. Thus, we coded, by default, a study as low risk of bias if all criteria were assessed as low risk of bias; otherwise, we coded it as high risk of bias. </p> </section> <section id="MR000040-sec-0030"> <h4 class="title">Dealing with missing data</h4> <p>We contacted authors of the included studies in an attempt to obtain unpublished data, to clarify issues on our 'Risk of bias' assessments, or to receive copies of unpublished protocols (<a href="./appendices#MR000040-sec-0057">Appendix 4</a>). When we received unpublished data, we analysed the data according to the methods used in the original studies. </p> <p>We included one study that investigated a mixture of opinion pieces and narrative reviews, but which did not report results stratified by document type. However, coding of financial conflicts of interest and recommendations were reported separately for each document (<a href="./references#MR000040-bbs2-0009" title="HayesMJ , PrasadV . Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma. Journal of Cancer Policy2019;21:100189. ">Hayes 2019</a>). As the type of document (e.g. opinion piece) was not coded in the original study, two review authors (CHN and AL) independently coded the type of documents to enable inclusion in our meta‐analyses. </p> </section> <section id="MR000040-sec-0031"> <h4 class="title">Assessment of heterogeneity</h4> <p>Statistical heterogeneity was described using the I<sup>2</sup> statistic. </p> <p>To further address statistical heterogeneity, we calculated prediction intervals for our primary analyses. We only calculated prediction intervals when at least four studies were included in the pooled analysis, because intervals will be imprecise when the effect estimates are based on only a few studies. A prediction interval presents the expected range of true effects in similar studies, is not influenced by sample size, and shows whether the study effects are dispersed over a wide range (<a href="./references#MR000040-bbs2-0154" title="IntHoutJ , IoannidisJP , RoversMM , GoemanJJ . Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open2016;6(7):e010247.">IntHout 2016</a>). A prediction interval thereby shows the range of risk ratios (RRs) that can be expected from similar studies, and, thus, a broad prediction interval indicates heterogeneity and uncertainty. To calculate prediction intervals, we used the formula presented by Riley and colleagues (<a href="./references#MR000040-bbs2-0162" title="RileyRD , HigginsJP , DeeksJJ . Interpretation of random effects meta-analyses. BMJ2011;342:d549.">Riley 2011</a>) (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). </p> </section> <section id="MR000040-sec-0032"> <h4 class="title">Data synthesis</h4> <p><i>Data management of individual studies</i> </p> <p>In our primary analyses, we used the definitions and coding of recommendations and conflicts of interest used by the authors of the included studies. If an ordinal scale was used to grade recommendations (e.g. highly positive, positive, neutral, negative, and highly negative), we recoded recommendations into two categories (i.e. favourable versus neutral/unfavourable recommendations). </p> <p>If the sample of documents included in a study contained a mixture of types of documents (e.g. both clinical guidelines and research papers), we only included the study in our pooled analyses if we could get separate data for the types of documents relevant for our review. </p> <p>In our analyses on clinical guidelines, we included one study that investigated 13 guidelines that each included recommendations on 24 different drugs (<a href="./references#MR000040-bbs2-0013" title="NorrisSL , HolmerHK , OgdenLA , BurdaBU , FuR . Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLOS One2013;8(10):e75284. ">Norris 2013</a>). To allow for this type of panel data, we used Poisson Generalised Estimating Equations to calculate effect estimates we could include in our pooled analyses (<a href="./references#MR000040-bbs2-0156" title="LumleyT , KronmalR , ShuanggeM . Relative risk regression in medical research: models, contrasts, estimators, and algorithms. UW Biostatistics Working Paper Series2006;Working Paper 293:http://biostats.bepress.com/uwbiostat/paper293.">Lumley 2006</a>). </p> <p>In our analyses on advisory committee reports, we included studies with two types of analysis units: committee members and their individual votes (individual level) and committee reports and the overall voting outcome (meeting level). In our primary analysis, we analysed data on meeting level as this level of analysis was most comparable to recommendations in the other types of documents (e.g. clinical guidelines). </p> <p>In some cases the same document was included in two separate studies. When we had access to unpublished data it was possible to remove the duplicate documents and we chose to remove it from the study with the latest publication date. We included two studies that investigated some of the same FDA advisory committee reports (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>) and removed duplicates from the study by Ackerley and colleagues (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>). We included two studies that investigated editorials published in some of the same oncology journals in overlapping time periods (<a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>; <a href="./references#MR000040-bbs2-0010" title="LernerTG , MirandaMC , LeraAT , UedaA , BrionesB , Del GiglioA , et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemporary Clinical Trials2012;33(5):1019-22. ">Lerner 2012</a>) and removed duplicates from the study by Bariani and colleagues (<a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>). </p> <p><i>Primary analysis</i> </p> <p>Due to expected clinical and methodological heterogeneity among the included studies, we used inverse variance random‐effects models to estimate RRs with 95% CIs. We compared recommendations between documents with and without conflicts of interest and ensured uniform directionality so RR &gt; 1 indicated that documents with conflicts of interest more often had favourable recommendations than documents without conflicts of interest. We analysed financial and non‐financial conflicts of interests separately, and analysed clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews separately. </p> <p>Using the methods for calculating a Number Needed to Treat, we calculated a Number Needed to Read for each document type (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>) (<a href="./references#MR000040-bbs2-0163" title="SchünemannHJ , VistGE , HigginsJPT , SantessoN , DeeksJJ , GlasziouP , AklEA , GuyattGH . Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schünemann 2020</a>). We defined Number Needed to Read as the expected number of documents with conflicts of interest needed to be read rather than documents without conflicts of interest for one additional document having a favourable recommendation. As describing the 95% CI is difficult for Number Needed to Read when the CI of the RR crosses the boundary of no difference (<a href="./references#MR000040-bbs2-0131" title="AltmanDG . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309-12.">Altman 1998</a>), we report the 95% CI of the Number Needed to Read in <a href="./appendices#MR000040-sec-0059">Appendix 6</a>. </p> <p><i>Secondary analyses</i> </p> <p>We analysed advisory committee reports on an individual level.</p> <p>In a post‐hoc analysis, we combined all four types of documents (i.e. clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews) in an analysis of financial conflicts of interest. </p> </section> <section id="MR000040-sec-0033"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct the following pre‐planned subgroup analyses for our primary analyses for all document types (<a href="./appendices#MR000040-sec-0060">Appendix 7</a>): </p> <p> <ul id="MR000040-list-0004"> <li> <p>Documents stratified by different types of financial conflicts of interest (e.g. funding, investigator, author grants, honorarium, consulting, speaker’s bureau, equity/stock, gifts) </p> </li> <li> <p>Studies assessed as high risk of bias versus studies assessed as low risk of bias</p> </li> </ul> </p> <p>We planned to conduct the following pre‐planned subgroup analysis for our primary analysis on clinical guidelines only: </p> <p> <ul id="MR000040-list-0005"> <li> <p>Clinical guidelines developed using standardised methods (e.g. GRADE (<a href="./references#MR000040-bbs2-0148" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011</a>) or USPSTF (<a href="./references#MR000040-bbs2-0166" title="US Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. https://www.uspreventiveservicestaskforce.org/Page/Name/procedure-manual (accessed 31 Jan 2018).">U.S. Preventive Services Task Force 2015</a>)) versus clinical guidelines not developed using standardised methods. For the stratification of documents, we relied on the coding done by the authors of the included studies </p> </li> </ul> </p> <p>In addition, we conducted the following post‐hoc subgroup analyses for our primary analyses. </p> <p> <ul id="MR000040-list-0006"> <li> <p>Documents stratified by degree of financial conflicts of interest: we compared major financial conflicts of interest (defined as at least half of the authors/committee members having financial conflicts of interest) with minor financial conflicts of interest (defined as less than half of the authors/committee members with financial conflicts of interest). The purpose of this subgroup analysis was to investigate a potential dose‐response relationship between financial conflicts of interest and recommendations. </p> </li> </ul> </p> <p>We only carried out the subgroup analyses when we had sufficient data (i.e. at least five documents in the groups with and without conflicts of interest in the included studies combined). </p> </section> <section id="MR000040-sec-0034"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct the following pre‐planned sensitivity analyses for our primary analyses (<a href="./appendices#MR000040-sec-0061">Appendix 8</a>). </p> <p> <ul id="MR000040-list-0007"> <li> <p>Excluding documents with unclear or undisclosed conflicts of interest.</p> </li> <li> <p>Excluding documents with neutral recommendations.</p> </li> <li> <p>Excluding all studies which disclosed a relevant conflict of interest. For example, if one of the included studies was funded by a drug company, we excluded the study and re‐analysed our data. </p> </li> <li> <p>Re‐analysing our primary analyses using a fixed‐effect model.</p> </li> </ul> </p> <p>In addition, we conducted the following post‐hoc sensitivity analyses for our primary analyses. </p> <p> <ul id="MR000040-list-0008"> <li> <p>Re‐categorising documents with financial conflicts of interest into documents with financial conflicts of interest related to the manufacturer of the drug or device of interest or to any for‐profit organisation in two separate analyses. </p> </li> </ul> </p> <p>We only carried out the sensitivity analyses when we had sufficient data (i.e. at least five documents in the groups with and without conflicts of interest in the included studies combined). </p> <p>We conducted all analyses in Review Manager (RevMan 5.4) and Stata 15.</p> </section> <section id="MR000040-sec-0035"> <h4 class="title">Assessment of the certainty of the evidence</h4> <p>Based on prior experience, using formal systems such as GRADE for assessing the certainty of evidence from methodological studies is challenging. We therefore focused on interpreting our results in the context of the statistical precision of our estimates (i.e. width of CIs) and risk of confounding. In <a href="./appendices#MR000040-sec-0062">Appendix 9</a>, we report GRADE assessments employing both an approach similar to observational intervention studies and to prognostic studies (<a href="./references#MR000040-bbs2-0147" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6.">Guyatt 2008</a>; <a href="./references#MR000040-bbs2-0145" title="ForoutanF , GuyattG , ZukV , VandvikPO , AlbaAC , MustafaR , et al. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. Journal of Clinical Epidemiology2020;121:62-70.">Foroutan 2020</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="MR000040-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="MR000040-sec-0036"></div> <section id="MR000040-sec-0037"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#MR000040-sec-0071" title="">Characteristics of included studies</a>. </p> <section id="MR000040-sec-0038"> <h4 class="title">Results of the search</h4> <p>See: <a href="#MR000040-fig-0001">Figure 1</a> </p> <div class="figure" id="MR000040-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="MR000040-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>In total, 9973 records were identified through our database searches. After removing duplicates, we screened 8422 records based on titles and abstracts and assessed 127 full‐text papers for inclusion. In total, we included 21 studies. We did not identify any unpublished studies or protocols for planned studies. </p> </section> <section id="MR000040-sec-0039"> <h4 class="title">Included studies</h4> <p>See: <a href="./references#MR000040-sec-0071" title="">Characteristics of included studies</a>. </p> <p>The 21 studies were published between 1998 and 2019. Eight studies investigated clinical guidelines (median number of clinical guidelines: nine, range: 2 to 50), seven studies investigated FDA drug and/or device advisory committee reports (median number of advisory committee reports: 376, range: 79 to 416), six studies investigated opinion pieces (editorials, commentaries, and letters; median number of opinion pieces: 44, range: 8 to 131), and five studies investigated narrative reviews (median number of narrative reviews: 84, range: 7 to 213). Sixteen studies investigated documents on drugs, three studies investigated documents on devices, and two studies investigated documents on both drugs and devices. Twenty studies only investigated financial conflicts of interest and one study investigated both financial conflicts of interest and specialty affiliations among guideline authors (i.e. non‐financial conflicts of interest). None of the included studies reported industry funding, but six studies did not report funding information. Seven of the included studies investigating documents with and without financial conflicts of interest were conducted by authors who themselves had financial conflicts of interest. </p> <p>We received unpublished data from 11 studies. In eight cases, we obtained full unpublished data sets (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>; <a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>; <a href="./references#MR000040-bbs2-0006" title="DunnAG , ZhouX , HudginsJ , ArachiD , MandlKD , CoieraE , et al. Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors. Journal of Clinical Epidemiology2016;80:43-9. ">Dunn 2016</a>; <a href="./references#MR000040-bbs2-0008" title="HartogCS , SkupinH , NatansonC , SunJ , ReinhartK . Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Medicine2012;38(8):1258-71. ">Hartog 2012</a>; <a href="./references#MR000040-bbs2-0010" title="LernerTG , MirandaMC , LeraAT , UedaA , BrionesB , Del GiglioA , et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemporary Clinical Trials2012;33(5):1019-22. ">Lerner 2012</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>; <a href="./references#MR000040-bbs2-0019" title="WangAT , McCoyCP , MuradMH , MontoriVM . Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ2010;340:c1344. ">Wang 2010</a>; <a href="./references#MR000040-bbs2-0021" title="ZhangAD , SchwartzJL , RossJS . Association between Food and Drug Administration advisory committee recommendations and agency actions, 2008-2015. Milbank Quarterly2019;97(3):796-819. ">Zhang 2019</a>), and in three cases we obtained additional summary data (<a href="./references#MR000040-bbs2-0014" title="Pham-KanterG . Revisiting financial conflicts of interest in FDA advisory committees. Milbank Quarterly2014;92(3):446-70. ">Pham‐Kanter 2014</a>; <a href="./references#MR000040-bbs2-0017" title="TibauA , BedardPL , SrikanthanA , EthierJL , Vera-BadilloFE , TempletonAJ , et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. Journal of Clinical Oncology2015;33(1):100-6. ">Tibau 2015</a>; <a href="./references#MR000040-bbs2-0018" title="TibauA , OcanaA , AngueraG , SerugaB , TempletonAJ , BarnadasA , et al. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration. JAMA Oncology2016;2(6):744-50. ">Tibau 2016</a>). </p> </section> </section> <section id="MR000040-sec-0040"> <h3 class="title">Risk of bias in included studies</h3> <p>See: <a href="#MR000040-fig-0002">Figure 2</a>; <a href="#MR000040-fig-0003">Figure 3</a>. </p> <div class="figure" id="MR000040-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000040-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="MR000040-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000040-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We assessed 20 studies as overall high risk of bias and one study as low risk of bias. Around half of the included studies had low risk of bias in the document inclusion process (n = 10) and the majority had low risk of bias in the coding of conflicts of interest (n = 15) and recommendations (n = 17). We assessed six studies to be low risk of confounding and 15 to be high risk of confounding, because they included documents of different topics (e.g. various cancer drugs for different indications), or included documents on the same drug used for different indications (e.g. antidiabetic drugs used in adults, children, or pregnant women). </p> <p>We found no published protocols and only received unpublished protocols for two studies (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>). We found no discrepancies between outcomes in these protocols and study publications. Nine of 21 author teams replied that no protocol existed for their study, and two author teams supplied us with reports that we did not consider to be protocols (<a href="./appendices#MR000040-sec-0057">Appendix 4</a>). </p> </section> <section id="MR000040-sec-0041"> <h3 class="title" id="MR000040-sec-0041">Effect of methods</h3> <p><b>Financial conflicts of interest: differences in recommendations</b> </p> <p><i>Clinical guidelines</i> </p> <p>Eight studies investigated a total of 106 clinical guidelines and data from four of these studies including 86 clinical guidelines could be used in our pooled primary analysis (<a href="./references#MR000040-bbs2-0001" title="AakreKM , WatineJ , BuntingPS , SandbergS , OosterhuisWP . Self-monitoring of blood glucose in patients with diabetes who do not use insulin - are guidelines evidence-based?Diabetic Medicine2012;29(10):1226-36. ">Aakre 2012</a>; <a href="./references#MR000040-bbs2-0013" title="NorrisSL , HolmerHK , OgdenLA , BurdaBU , FuR . Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLOS One2013;8(10):e75284. ">Norris 2013</a>; <a href="./references#MR000040-bbs2-0017" title="TibauA , BedardPL , SrikanthanA , EthierJL , Vera-BadilloFE , TempletonAJ , et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. Journal of Clinical Oncology2015;33(1):100-6. ">Tibau 2015</a>; <a href="./references#MR000040-bbs2-0019" title="WangAT , McCoyCP , MuradMH , MontoriVM . Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ2010;340:c1344. ">Wang 2010</a>). The association between financial conflicts of interest and favourable recommendations in clinical guidelines was RR: 1.26, 95% CI: 0.93 to 1.69, I<sup>2</sup>: 0% (<a href="./references#MR000040-fig-0004" title="">Analysis 1.1</a>). The Number Needed to Read for clinical guidelines was 9.1 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). </p> <p>The prediction interval for the RR was 0.65 to 2.43 (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). Thus, one can expect that clinical guidelines with financial conflicts of interest more often have favourable recommendations compared with clinical guidelines without financial conflicts of interest, but for an individual study of clinical guidelines the association may be reversed. </p> <p>Four included studies did not report data in a way that enabled us to include them in our pooled analysis. Two studies each investigated one clinical guideline with financial conflicts of interest and one without. In both of these studies the clinical guidelines with financial conflicts of interest had a favourable recommendation, whereas the clinical guidelines without had a unfavourable recommendation (<a href="./references#MR000040-bbs2-0007" title="GeorgeJN , VeselySK , WoolfSH . Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. American Journal of Medical Quality2014;29(1):53-60. ">George 2014</a>; <a href="./references#MR000040-bbs2-0015" title="SchottG , DunnweberC , MuhlbauerB , NieblingW , PachlH , LudwigWD . Does the pharmaceutical industry influence guidelines?: two examples from Germany. Deutsches Ärzteblatt International2013;110(35-36):575-83. ">Schott 2013</a>). One study investigated 12 clinical guidelines, but only reported the percentage of authors with financial conflicts of interest in each guideline. Three out of eight clinical guidelines with favourable recommendations included authors with financial conflicts of interest (prevalence from 12% to 53%), and two out of four clinical guidelines with unfavourable recommendations included authors with financial conflicts of interest (prevalence 9% and 11%) (<a href="./references#MR000040-bbs2-0012" title="NorrisSL , BurdaBU , HolmerHK , OgdenLA , FuR , BeroL , et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology2012;65(7):725-33. ">Norris 2012</a>). The remaining study investigated a mixture of four clinical guidelines, 23 editorials and commentaries, and 40 reviews (mainly narrative) commenting on a randomised trial on fenofibrate use. The authors found that documents written by authors with conflicts of interest more often recommended fibrate use (RR: 1.69, 95% CI: 1.07 to 2.67) (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>). </p> <p>One of the studies included in our pooled analysis adjusted for the specific drug that was evaluated in the guideline (thereby reducing the risk of confounding). The authors found no association between financial conflicts of interest and recommendations of a drug, but did not report any effect estimates in the study publication (<a href="./references#MR000040-bbs2-0013" title="NorrisSL , HolmerHK , OgdenLA , BurdaBU , FuR . Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLOS One2013;8(10):e75284. ">Norris 2013</a>). </p> <p><i>Advisory committee reports</i> </p> <p>Seven studies investigated a total of 1809 advisory committee reports and data from five studies could be included in our pooled analyses (<a href="./references#MR000040-bbs2-0002" title="AckerleyN , EyraudJ , FranzC , KisselB , MetivierD . Financial conflict-of-interest disclosure and voting patterns at FDA advisory committee meetings. Washington DC: Eastern Research Group (FDA Contract No. HHSF223200810071I), 2009. ">Ackerley 2009</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>; <a href="./references#MR000040-bbs2-0014" title="Pham-KanterG . Revisiting financial conflicts of interest in FDA advisory committees. Milbank Quarterly2014;92(3):446-70. ">Pham‐Kanter 2014</a>; <a href="./references#MR000040-bbs2-0018" title="TibauA , OcanaA , AngueraG , SerugaB , TempletonAJ , BarnadasA , et al. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration. JAMA Oncology2016;2(6):744-50. ">Tibau 2016</a>; <a href="./references#MR000040-bbs2-0021" title="ZhangAD , SchwartzJL , RossJS . Association between Food and Drug Administration advisory committee recommendations and agency actions, 2008-2015. Milbank Quarterly2019;97(3):796-819. ">Zhang 2019</a>). In our primary analysis, including four studies of 629 advisory committee reports, the association between any advisory committee report with members with financial conflicts of interest and voting in favour of approving a drug or device was RR: 1.20, 95% CI: 0.99 to 1.45, I<sup>2</sup>: 24% (<a href="./references#MR000040-fig-0004" title="">Analysis 1.1</a>). The Number Needed to Read for advisory committee reports was 7.7 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). In our secondary analysis, including three studies of 17,816 votes, the association between financial conflicts of interest of individual advisory committee members and voting in favour of approving a drug or device was RR: 1.14, 95% CI: 1.07 to 1.21, I<sup>2</sup>: 35% (<a href="./references#MR000040-fig-0005" title="">Analysis 2.1</a>). </p> <p>The prediction interval for the RR was 0.66 to 2.19 (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). Thus, one can expect that advisory committee reports with financial conflicts of interest more often have favourable recommendations compared with advisory committee reports without financial conflicts of interest, but for an individual study of advisory committee reports the association may be reversed. </p> <p>Two included studies did not report data in a way that enabled us to include them in our pooled analysis. One of the studies investigated the association between conflicts of interest and voting behaviour of 1482 members from 385 advisory committee reports. The authors reported that they found no association between conflicts of interest and voting outcome among members, but did not report any effect estimates on the association (<a href="./references#MR000040-bbs2-0020" title="XuJ , EmenanjoO , OrtwerthM , LurieP . Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings-a cross-sectional study. JAMA Internal Medicine2017;177(7):1038-40. ">Xu 2017</a>). The remaining study investigated 1483 members from 416 advisory committee reports. The authors found that committee members with financial conflicts of interest had 14.3% greater odds of voting for approval compared with committee members without financial conflicts of interest. However, the estimate was not statistically significant (P value: 0.12) (<a href="./references#MR000040-bbs2-0004" title="CooperJC , GolecJ . Conflicts of interest on committees of experts: the case of Food and Drug Administration drug advisory committees. Journal of Law &amp; Economics2019;62(2):321-46. ">Cooper 2019</a>). </p> <p>One of the studies included in the pooled analysis adjusted for medical product and advisory committee meeting characteristics (thereby reducing the risk of confounding) and the association between financial conflicts of interest related to the manufacturing company and favourable recommendations was odds ratio (OR): 4.66, 95% CI: 0.64 to 33.6 (<a href="./references#MR000040-bbs2-0021" title="ZhangAD , SchwartzJL , RossJS . Association between Food and Drug Administration advisory committee recommendations and agency actions, 2008-2015. Milbank Quarterly2019;97(3):796-819. ">Zhang 2019</a>). </p> <p><i>Opinion pieces</i> </p> <p>Six studies investigated a total of 340 opinion pieces (<a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>; <a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>; <a href="./references#MR000040-bbs2-0009" title="HayesMJ , PrasadV . Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma. Journal of Cancer Policy2019;21:100189. ">Hayes 2019</a>; <a href="./references#MR000040-bbs2-0010" title="LernerTG , MirandaMC , LeraAT , UedaA , BrionesB , Del GiglioA , et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemporary Clinical Trials2012;33(5):1019-22. ">Lerner 2012</a>; <a href="./references#MR000040-bbs2-0016" title="StelfoxHT , ChuaG , O'RourkeK , DetskyAS . Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine1998;338(2):101-6. ">Stelfox 1998</a>; <a href="./references#MR000040-bbs2-0019" title="WangAT , McCoyCP , MuradMH , MontoriVM . Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ2010;340:c1344. ">Wang 2010</a>) and data from four of these studies including 284 opinion pieces could be included in our pooled primary analysis. The association between financial conflicts of interest and favourable recommendations in opinion pieces was RR: 2.62, 95% CI: 0.91 to 7.55, I<sup>2</sup>: 78% (<a href="./references#MR000040-fig-0004" title="">Analysis 1.1</a>). The Number Needed to Read for opinion pieces was 2.3 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). </p> <p>The prediction interval for the RR was 0.03 to 220.56 (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). Thus, one can expect that opinion pieces with financial conflicts of interest more often have favourable recommendations compared with opinion pieces without financial conflicts of interest, but for an individual study of opinion pieces the association may be reversed. </p> <p>Two included studies did not report data in a way that enabled us to include them in our pooled analysis. One study investigated a mixture of 69 authors of original research papers, review articles, and letters. The study found that authors with financial conflicts of interest related to the drug manufacturer more often had favourable recommendations than authors without financial conflicts of interest (RR: 13.91, 95% CI: 1.99 to 96.97) (<a href="./references#MR000040-bbs2-0016" title="StelfoxHT , ChuaG , O'RourkeK , DetskyAS . Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine1998;338(2):101-6. ">Stelfox 1998</a>). The remaining study investigated a mixture of four clinical guidelines, 23 editorials and commentaries, and 40 reviews (mainly narrative) and found that documents written by authors with conflicts of interest more often recommended fibrate use (RR: 1.69, 95% CI: 1.07 to 2.67) (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>). </p> <p>One of the studies included in the pooled analysis adjusted for characteristics of the trial (e.g. type of intervention and trial conclusion) the editorial commented on (thereby reducing the risk of confounding) and the association between financial conflicts of interest and favourable recommendations was OR: 1.39, 95% CI: 0.52 to 3.70 (<a href="./references#MR000040-bbs2-0003" title="BarianiGM , FerrariAC , HoffPM , KrzyzanowskaMK , RiechelmannRP . Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Journal of Clinical Oncology2013;31(18):2289-95. ">Bariani 2013</a>). </p> <p><i>Narrative reviews</i> </p> <p>Five studies investigated a total of 497 narrative reviews and data from four of these studies investigating 457 narrative reviews could be included in our pooled primary analysis (<a href="./references#MR000040-bbs2-0006" title="DunnAG , ZhouX , HudginsJ , ArachiD , MandlKD , CoieraE , et al. Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors. Journal of Clinical Epidemiology2016;80:43-9. ">Dunn 2016</a>; <a href="./references#MR000040-bbs2-0008" title="HartogCS , SkupinH , NatansonC , SunJ , ReinhartK . Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Medicine2012;38(8):1258-71. ">Hartog 2012</a>; <a href="./references#MR000040-bbs2-0009" title="HayesMJ , PrasadV . Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma. Journal of Cancer Policy2019;21:100189. ">Hayes 2019</a>; <a href="./references#MR000040-bbs2-0019" title="WangAT , McCoyCP , MuradMH , MontoriVM . Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ2010;340:c1344. ">Wang 2010</a>). The association between financial conflicts of interest and favourable recommendations in narrative reviews was RR: 1.20, 95% CI: 0.97 to 1.49, I<sup>2</sup>: 39% (<a href="./references#MR000040-fig-0004" title="">Analysis 1.1</a>). The Number Needed to Read for narrative reviews was 8.3 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). </p> <p>The prediction interval for the RR of was 0.56 to 2.59 (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). Thus, one can expect that narrative reviews with financial conflicts of interest more often have favourable recommendations compared with narrative reviews without financial conflicts of interest, but for an individual study of narrative reviews the association may be reversed. </p> <p>One included study did not report data in a way that enabled us to include it in our pooled analysis. The study investigated a mixture of four clinical guidelines, 23 editorials and commentaries, and 40 reviews (mainly narrative). The authors found that documents written by authors with conflicts of interest more often recommended fibrate use (RR: 1.69, 95% CI: 1.07 to 2.67) (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>). </p> <p><b>Post‐hoc analysis combining all document types. Financial conflicts of interest: differences in recommendations</b> </p> <p>In a post‐hoc analysis, we combined all types of documents and the association between financial conflicts of interest and favourable recommendations was RR: 1.26, 95% CI: 1.09 to 1.44, I<sup>2</sup>: 38% (<a href="./references#MR000040-fig-0004" title="">Analysis 1.1</a>). The Number Needed to Read was 7.1 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). </p> <p>The prediction interval for the RR was 0.88 to 1.80 (<a href="./appendices#MR000040-sec-0058">Appendix 5</a>). Thus, one can expect that documents with financial conflicts of interest more often have favourable recommendations compared with documents without financial conflicts of interest, but for an individual study the association may be reversed. </p> <p><b>Non‐financial conflicts of interest: differences in recommendations</b> </p> <p>One study investigated specialty interests and included 12 clinical guidelines on mammography screening. The focus was whether the guideline author team included a radiologist (<a href="./references#MR000040-bbs2-0012" title="NorrisSL , BurdaBU , HolmerHK , OgdenLA , FuR , BeroL , et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology2012;65(7):725-33. ">Norris 2012</a>). In our analysis based on this study, the association between having radiologists in the guideline panel and recommending routine screening for breast cancer was RR: 2.10, 95% CI: 0.92 to 4.77. The Number Needed to Read was 2.1 (<a href="./appendices#MR000040-sec-0059">Appendix 6</a>). </p> <p><b>Subgroup and sensitivity analyses</b> </p> <p>We found no differences in effect estimates in relation to the type of financial conflicts of interest or the degree of financial conflicts of interest for any document type. We were not able to conduct the planned subgroup analyses in relation to risk of bias in included studies for all document types and development methods for clinical guidelines (<a href="./appendices#MR000040-sec-0060">Appendix 7</a>). </p> <p>Sensitivity analyses were robust in 20 of 23 analyses of financial conflicts of interest and in three analyses the association between financial conflicts of interest and favourable recommendations became stronger (<a href="./appendices#MR000040-sec-0061">Appendix 8</a>). </p> <p><b>Assessment of certainty of the evidence</b> </p> <p>The evidence on financial conflicts of interest in all four types of documents and non‐financial conflicts of interest in clinical guidelines should be interpreted with some caution as the majority of the studies (15 out of 21) had a risk of confounding and all effect estimates of the primary analyses lacked statistical precision. Using the GRADE approaches for intervention and prognostic studies resulted in low to very low certainty of the evidence depending on type of document and the GRADE system used (<a href="./appendices#MR000040-sec-0062">Appendix 9</a>). </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="MR000040-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="MR000040-sec-0042"></div> <section id="MR000040-sec-0043"> <h3 class="title" id="MR000040-sec-0043">Summary of main results</h3> <p>We included 21 studies investigating 106 clinical guidelines, 1809 advisory committee reports, 340 opinion pieces, and 497 narrative reviews. We found an association between financial conflicts of interest and favourable recommendations of drugs and devices in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. Our four primary analyses pointed in a consistent direction and provided a fairly similar magnitude of effect, but each with varying degrees of statistical precision. Our post hoc analysis combining all document types confirmed these findings and increased the statistical precision. Our findings on the impact of non‐financial conflicts of interest on recommendations were limited to evidence from a single study of breast cancer screening guidelines with involvement of radiologist authors, with statistically imprecise results. It is therefore uncertain whether specialty interests or other types of non‐financial conflicts of interest impact on recommendations. </p> </section> <section id="MR000040-sec-0044"> <h3 class="title" id="MR000040-sec-0044">Quality of the evidence</h3> <p>All but one of the included studies were assessed as having high risk of bias, mainly due to a high risk of confounding. Documents differed in other aspects than conflicts of interest (e.g. they investigated different drugs used for different patient groups) which could have introduced confounding. For example, if a study included editorials in oncology commenting on numerous drugs. If some drugs are more likely to have editorials written by authors with conflicts of interest (e.g. developed by major drug companies), and if such drugs are more likely to have favourable trial results (i.e. thereby receiving a favourable recommendation in an editorial), this could confound the association between financial conflicts of interest and favourable recommendations. </p> </section> <section id="MR000040-sec-0045"> <h3 class="title" id="MR000040-sec-0045">Strengths and limitations</h3> <p>A major strength of our study is the inclusion of unpublished data from 11 of 21 studies. We retrieved eight full datasets and unpublished summary data for three additional studies which enabled us to ensure high data quality and to conduct comprehensive analyses thereby increasing statistical precision and minimising reporting bias. Furthermore, we did a thorough search for grey literature and attempted to identify published and unpublished protocols. We only obtained two protocols (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>; <a href="./references#MR000040-bbs2-0011" title="LurieP , AlmeidaCM , StineN , StineAR , WolfeSM . Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA2006;295(16):1921-8. ">Lurie 2006</a>) and a comparison of outcomes in the protocols with outcomes in the study publications gave no indication of selective outcome reporting. </p> <p>However, six of 21 included studies were reported in a format that did not allow inclusion in meta‐analysis. Four of these studies reported results similar to our meta‐analysis. Two of the four studies combined different types of documents without stratifying results, with estimates RR: 1.69, 95% CI: 1.07 to 2.67 and RR: 13.91, 95% CI: 1.99 to 96.97) in line with our primary analysis (<a href="./references#MR000040-bbs2-0005" title="DowningNS , ChengT , KrumholzHM , ShahND , RossJS . Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis. JAMA Internal Medicine2014;174(7):1176-82. ">Downing 2014</a>; <a href="./references#MR000040-bbs2-0016" title="StelfoxHT , ChuaG , O'RourkeK , DetskyAS . Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine1998;338(2):101-6. ">Stelfox 1998</a>). The other two of the four studies sampled a single pair of clinical guidelines with and without financial conflicts of interest and in both cases guidelines with conflicts were favourable (<a href="./references#MR000040-bbs2-0007" title="GeorgeJN , VeselySK , WoolfSH . Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. American Journal of Medical Quality2014;29(1):53-60. ">George 2014</a>; <a href="./references#MR000040-bbs2-0015" title="SchottG , DunnweberC , MuhlbauerB , NieblingW , PachlH , LudwigWD . Does the pharmaceutical industry influence guidelines?: two examples from Germany. Deutsches Ärzteblatt International2013;110(35-36):575-83. ">Schott 2013</a>). The last two of the six studies (29% of all documents) (<a href="./references#MR000040-bbs2-0004" title="CooperJC , GolecJ . Conflicts of interest on committees of experts: the case of Food and Drug Administration drug advisory committees. Journal of Law &amp; Economics2019;62(2):321-46. ">Cooper 2019</a>; <a href="./references#MR000040-bbs2-0020" title="XuJ , EmenanjoO , OrtwerthM , LurieP . Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings-a cross-sectional study. JAMA Internal Medicine2017;177(7):1038-40. ">Xu 2017</a>) sampled FDA committee reports from the same period as the studies included in our meta‐analysis, implying a considerable risk of overlapping documents between the studies. The two studies reported no results for our primary analysis and if we had access to raw data we would likely have had to exclude a considerable proportion of the documents from our analyses to avoid double‐counting. Thus, we find it unlikely that our result would have been qualitatively different had the six studies reported results in a format suitable for meta‐analysis. </p> <p>Furthermore, our findings on the influence of financial conflicts of interest were robust in most of our sensitivity analyses. When our analyses were not robust, the sensitivity analyses generally showed a stronger association between financial conflicts of interest and favourable recommendations. </p> <p>Nevertheless, there are some challenges. First, the different types of documents were described using various terms in the included studies and despite using a comprehensive search strategy we might have missed relevant studies. Furthermore, only four studies were included in each of our four primary analyses. Therefore, our effect estimates have some degree of statistical imprecision and none of our primary analyses were statistically significant at the conventional 5% level. However, the sizes of the effect estimates were similar for clinical guidelines, advisory committee reports, and narrative reviews and slightly higher for opinion pieces, and when we combined all document types in a post hoc analysis including 13 studies, we increased the statistical precision and found a statistically significant association with moderate heterogeneity. </p> <p>Second, our criteria for assessment of risk of bias in relation to confounding might be viewed as quite strict and others may interpret the risk of bias in studies differently. Nevertheless, the majority of studies had a risk of confounding as they compared documents that may differ in other aspects than conflicts of interest (e.g. documents on different drugs used for different patient groups). While confounding could have influenced our estimates, the association between conflicts of interest and recommendations was fairly consistent across document types despite some studies including quite comparable documents (e.g. clinical guidelines on efalizumab for treatment of psoriasis (<a href="./references#MR000040-bbs2-0015" title="SchottG , DunnweberC , MuhlbauerB , NieblingW , PachlH , LudwigWD . Does the pharmaceutical industry influence guidelines?: two examples from Germany. Deutsches Ärzteblatt International2013;110(35-36):575-83. ">Schott 2013</a>)), and others including quite different documents (e.g. advisory committee reports on a wide range of different drugs (<a href="./references#MR000040-bbs2-0014" title="Pham-KanterG . Revisiting financial conflicts of interest in FDA advisory committees. Milbank Quarterly2014;92(3):446-70. ">Pham‐Kanter 2014</a>)). Moreover, recommendations in guidelines and narrative reviews could have been influenced by conflicts of interest in the underlying evidence. For example, in certain clinical fields such as oncology (<a href="./references#MR000040-bbs2-0133" title="AndreatosN , ZacharioudakisIM , ZervouFN , MuhammedM , MylonakisE . Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industry. Medicine (Baltimore)2017;96(2):e5711.">Andreatos 2017</a>), conflicts of interest are highly frequent which could have impacted the conclusions of clinical trials and systematic reviews (<a href="./references#MR000040-bbs2-0158" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>; <a href="./references#MR000040-bbs2-0149" title="HansenC , LundhA , RasmussenK , HróbjartssonA . Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews2019, Issue 8. Art. No: MR000047. [DOI: 10.1002/14651858.MR000047.pub2]">Hansen 2019a</a>) and thereby indirectly affected guideline recommendations and potentially result in effect modification. Furthermore, how conflicts of interest in the primary clinical trials and systematic reviews underpinning a guideline are interpreted could be associated with the conflicts of interest of the guideline authors. </p> <p>Third, the number of authors with financial conflicts of interest may influence recommendations in a document. Our subgroup analyses comparing documents with the majority of authors with financial conflicts of interest versus a minority of authors found no difference in effect. However, the analyses were somehow simplistic and based on few data with statistically imprecise results. Another important aspect is the role of the author with financial conflicts of interest. For example, the chair of a guideline committee or the lead author of a narrative review likely has greater influence on recommendations than an author with a less prominent role. Unfortunately, none of the included studies reported data that allowed such a comparison. </p> <p>Fourth, 11 of the 21 included studies relied solely on disclosed information in the included documents for coding conflicts of interest. This could have led to an underestimation of our effect estimates, as conflicts of interest are often underreported in various publication types, including clinical guidelines (<a href="./references#MR000040-bbs2-0042" title="BindslevJB , SchrollJ , GøtzschePC , LundhA . Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Medical Ethics2013;14:19. ">Bindslev 2013</a>). </p> <p>Finally, the interpretation of our results can be debated. There is no published guidance specifically tailored for summarising and interpreting evidence from methodological studies. One approach could be to use the GRADE system (<a href="./references#MR000040-bbs2-0147" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6.">Guyatt 2008</a>), but it is questionable whether using GRADE for observational intervention studies or prognostic studies is best suited for methodological studies, since the methodology of studies or the presence of conflicts of interest cannot be randomised. In <a href="./appendices#MR000040-sec-0062">Appendix 9</a>, we report assessments using both strategies which resulted in low to very low certainty of evidence depending on type of documents and the system used. Using the GRADE approach for intervention studies resulted in a more conservative interpretation of the certainty of the evidence. </p> </section> <section id="MR000040-sec-0046"> <h3 class="title" id="MR000040-sec-0046">Agreements and disagreements with other studies or reviews</h3> <p>Other systematic reviews have focused on financial conflicts of interest in other types of publications and have reported similar findings. A recent updated Cochrane Methodology Review focused on primary research, mainly trials, and found that industry‐funded studies more often had favourable conclusions compared with non‐industry‐funded studies (RR: 1.34, 95% CI: 1.19 to 1.51) (<a href="./references#MR000040-bbs2-0158" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>). Similarly, another recent Cochrane Methodology Review focused on systematic reviews and found that systematic reviews with industry funding or by authors with financial conflicts of interest more often had favourable conclusions compared with systematic reviews without financial conflicts of interest (RR: 1.98, 95% CI: 1.26 to 3.11) (<a href="./references#MR000040-bbs2-0149" title="HansenC , LundhA , RasmussenK , HróbjartssonA . Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews2019, Issue 8. Art. No: MR000047. [DOI: 10.1002/14651858.MR000047.pub2]">Hansen 2019a</a>). </p> <p>Financial conflicts of interest have also been investigated in relation to other industries and in a systematic review, Chartres and colleagues reported that industry‐funded nutrition studies and reviews more often had favourable conclusions than non‐industry‐funded nutrition studies and reviews (RR: 1.31, 95% CI: 0.99 to 1.72) (<a href="./references#MR000040-bbs2-0141" title="ChartresN , FabbriA , BeroLA . Association of industry sponsorship with outcomes of nutrition studies: a systematic review and meta-analysis. JAMA Internal Medicine2016;176(12):1769-77.">Chartres 2016</a>). </p> </section> <section id="MR000040-sec-0047"> <h3 class="title" id="MR000040-sec-0047">Meaning of our review</h3> <p>For our analyses, we included studies of four types of documents that both were fairly common and involved authors’ interpretation of external evidence (involving methods less stringent than in a systematic review). Although we had anticipated potential differences between the various types of documents, we found a fairly consistent association between financial conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews. One reason could be that authors with conflicts of interest are more prone to confirm prior beliefs by selectively citing and interpreting the literature (<a href="./references#MR000040-bbs2-0067" title="DuBroffR . Confirmation bias, conflicts of interest and cholesterol guidance: can we trust expert opinions?QJM : Monthly Journal of the Association of Physicians2018;111(10):687-9. ">DuBroff 2018</a>). This could also explain the somewhat stronger association found in opinion pieces which to some degree allow authors more room for interpretation than narrative reviews, which undergo peer review, and clinical guidelines, which are increasingly done using standardised methods. On an absolute scale, the association between conflicts of interest and recommendations was particularly strong for opinion pieces and specialty interest in clinical guidelines with Numbers Needed to Read of only 2.3 and 2.1, respectively, although the estimates had considerable statistical imprecision. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="MR000040-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="MR000040-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000040-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000040-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/full#MR000040-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Primary analyses, Outcome 1: Financial conflicts of interest" data-id="MR000040-fig-0004" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Primary analyses, Outcome 1: Financial conflicts of interest</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Secondary analysis: using individual voting level in the analysis on advisory committee reports, Outcome 1: Financial conflicts of interest" data-id="MR000040-fig-0005" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Secondary analysis: using individual voting level in the analysis on advisory committee reports, Outcome 1: Financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Subgroup analyses for clinical guidelines, Outcome 1: Different types of financial conflicts of interest" data-id="MR000040-fig-0006" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Subgroup analyses for clinical guidelines, Outcome 1: Different types of financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Subgroup analyses for clinical guidelines, Outcome 2: Clinical guidelines with major financial conflicts of interest versus clinical guidelines with minor financial conflicts of interest" data-id="MR000040-fig-0007" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Subgroup analyses for clinical guidelines, Outcome 2: Clinical guidelines with major financial conflicts of interest versus clinical guidelines with minor financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Subgroup analyses for advisory committee reports, Outcome 1: Different types of financial conflicts of interest" data-id="MR000040-fig-0008" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Subgroup analyses for advisory committee reports, Outcome 1: Different types of financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Subgroup analyses for advisory committee reports, Outcome 2: Advisory committee reports with major financial conflicts of interest versus advisory committee reports with minor financial conflicts of interest" data-id="MR000040-fig-0009" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Subgroup analyses for advisory committee reports, Outcome 2: Advisory committee reports with major financial conflicts of interest versus advisory committee reports with minor financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Subgroup analyses for opinion pieces, Outcome 1: Different types of financial conflicts of interest" data-id="MR000040-fig-0010" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Subgroup analyses for opinion pieces, Outcome 1: Different types of financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Subgroup analyses for opinion pieces, Outcome 2: Opinion pieces with major financial conflicts of interest versus opinion pieces with minor financial conflicts of interest" data-id="MR000040-fig-0011" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Subgroup analyses for opinion pieces, Outcome 2: Opinion pieces with major financial conflicts of interest versus opinion pieces with minor financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses for narrative reviews, Outcome 1: Different types of financial conflicts of interest" data-id="MR000040-fig-0012" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses for narrative reviews, Outcome 1: Different types of financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Subgroup analyses for narrative reviews, Outcome 2: Narrative reviews with major financial conflicts of interest versus narrative reviews with minor financial conflicts of interest" data-id="MR000040-fig-0013" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Subgroup analyses for narrative reviews, Outcome 2: Narrative reviews with major financial conflicts of interest versus narrative reviews with minor financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 1: Excluding clinical guidelines with unclear or undisclosed financial conflicts of interest" data-id="MR000040-fig-0014" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 1: Excluding clinical guidelines with unclear or undisclosed financial conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 2: Excluding clinical guidelines with neutral recommendations" data-id="MR000040-fig-0015" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 2: Excluding clinical guidelines with neutral recommendations </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 3: Excluding all studies of clinical guidelines which disclosed a relevant conflict of interest of study authors" data-id="MR000040-fig-0016" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 3: Excluding all studies of clinical guidelines which disclosed a relevant conflict of interest of study authors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses" data-id="MR000040-fig-0017" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer" data-id="MR000040-fig-0018" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-007.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company" data-id="MR000040-fig-0019" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-007.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-007.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 1: Excluding advisory committee reports with unclear or undisclosed conflicts of interest" data-id="MR000040-fig-0020" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 1: Excluding advisory committee reports with unclear or undisclosed conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 2: Excluding advisory committee reports with neutral recommendations" data-id="MR000040-fig-0021" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 2: Excluding advisory committee reports with neutral recommendations </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 3: Excluding all studies of advisory committee reports which disclose a relevant conflict of interest of study authors" data-id="MR000040-fig-0022" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 3: Excluding all studies of advisory committee reports which disclose a relevant conflict of interest of study authors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses" data-id="MR000040-fig-0023" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer" data-id="MR000040-fig-0024" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Sensitivity analyses for advisory committee reports, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 1: Excluding opinion pieces with unclear or undisclosed conflicts of interest" data-id="MR000040-fig-0025" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 1: Excluding opinion pieces with unclear or undisclosed conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 2: Excluding opinion pieces with neutral recommendations" data-id="MR000040-fig-0026" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 2: Excluding opinion pieces with neutral recommendations </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 3: Excluding all studies of opinion pieces which disclosed a relevant conflict of interest of study authors" data-id="MR000040-fig-0027" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 3: Excluding all studies of opinion pieces which disclosed a relevant conflict of interest of study authors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses" data-id="MR000040-fig-0028" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer" data-id="MR000040-fig-0029" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-009.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Sensitivity analyses for opinion pieces, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company" data-id="MR000040-fig-0030" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-009.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9: Sensitivity analyses for opinion pieces, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-009.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 1: Excluding narrative reviews with unclear or undisclosed conflicts of interest" data-id="MR000040-fig-0031" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 1: Excluding narrative reviews with unclear or undisclosed conflicts of interest </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 2: Excluding narrative reviews with neutral recommendations" data-id="MR000040-fig-0032" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 2: Excluding narrative reviews with neutral recommendations </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 3: Excluding all studies of narrative reviews which disclosed a relevant conflict of interest of study authors" data-id="MR000040-fig-0033" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 3: Excluding all studies of narrative reviews which disclosed a relevant conflict of interest of study authors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses" data-id="MR000040-fig-0034" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 4: Re‐analysing our primary analyses using fixed‐effect meta‐analyses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer" data-id="MR000040-fig-0035" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000040-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/urn:x-wiley:14651858:media:MR000040:MR000040-CMP-010.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Sensitivity analyses for narrative reviews, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company" data-id="MR000040-fig-0036" src="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_t/tMR000040-CMP-010.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10: Sensitivity analyses for narrative reviews, Outcome 6: Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/media/CDSR/MR000040/image_n/nMR000040-CMP-010.06.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary analyses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.09, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Clinical guidelines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.93, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Advisory committee reports</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.99, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Opinion pieces</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.62 [0.91, 7.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Narrative reviews</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.97, 1.49]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Primary analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary analysis: using individual voting level in the analysis on advisory committee reports</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [1.07, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Secondary analysis: using individual voting level in the analysis on advisory committee reports</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analyses for clinical guidelines</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Different types of financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Advisory board membership</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.24, 33.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Consultancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.24, 33.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 Grants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [0.20, 31.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.4 Honoraria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.24, 33.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.5 Industry funding of the clinical guideline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.88, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.6 Speaker fees</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.24, 33.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Clinical guidelines with major financial conflicts of interest versus clinical guidelines with minor financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Major financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.05, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Minor financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.68, 1.65]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analyses for clinical guidelines</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup analyses for advisory committee reports</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Different types of financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Consultancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.88, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Grants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.66, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.3 Investments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.91, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.4 Lecturing and honoraria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [1.10, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.5 Other relationships</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [1.02, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Advisory committee reports with major financial conflicts of interest versus advisory committee reports with minor financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Major financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.96, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Minor financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.97, 1.88]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup analyses for advisory committee reports</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analyses for opinion pieces</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Different types of financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Advisory board membership</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.58, 2.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Consultancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.52, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.3 Employment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [0.03, 231.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.4 Grants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.86, 3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.5 Honoraria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.35, 5.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.6 Lecture or speaker fees</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [0.51, 6.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.7 Other relationships</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.51, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.8 Stock ownership</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.22, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Opinion pieces with major financial conflicts of interest versus opinion pieces with minor financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Major financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.43 [2.24, 39.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Minor financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.60 [0.38, 82.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analyses for opinion pieces</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analyses for narrative reviews</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Different types of financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Advisory board membership</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.98, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Assistance provided by industry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [0.37, 30.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.3 Consultancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.94 [0.34, 25.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.4 Employment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [1.04, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.5 Grants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.29 [0.25, 42.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.6 Honoraria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.60, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.7 Industry funding of the review</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.65, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.8 Lecture or speaker fees</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.06, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.9 Other relationships</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.06, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.10 Travel grants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.94, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Narrative reviews with major financial conflicts of interest versus narrative reviews with minor financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Major financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.34, 26.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Minor financial conflicts of interest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.86, 1.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analyses for narrative reviews</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analyses for clinical guidelines</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Excluding clinical guidelines with unclear or undisclosed financial conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.71, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Excluding clinical guidelines with neutral recommendations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.71, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Excluding all studies of clinical guidelines which disclosed a relevant conflict of interest of study authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.90, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Re‐analysing our primary analyses using fixed‐effect meta‐analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.93, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.71, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.6 Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.96, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analyses for clinical guidelines</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analyses for advisory committee reports</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Excluding advisory committee reports with unclear or undisclosed conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.77, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Excluding advisory committee reports with neutral recommendations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.96, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Excluding all studies of advisory committee reports which disclose a relevant conflict of interest of study authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.08, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Re‐analysing our primary analyses using fixed‐effect meta‐analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.00, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.99, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Sensitivity analyses for advisory committee reports</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analyses for opinion pieces</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Excluding opinion pieces with unclear or undisclosed conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.53, 4.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Excluding opinion pieces with neutral recommendations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.77, 5.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Excluding all studies of opinion pieces which disclosed a relevant conflict of interest of study authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.84 [1.81, 8.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Re‐analysing our primary analyses using fixed‐effect meta‐analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.94, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.69 [4.10, 52.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.6 Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.45 [0.78, 7.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analyses for opinion pieces</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000040-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analyses for narrative reviews</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Excluding narrative reviews with unclear or undisclosed conflicts of interest <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.11, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Excluding narrative reviews with neutral recommendations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.97, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.3 Excluding all studies of narrative reviews which disclosed a relevant conflict of interest of study authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.68, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.4 Re‐analysing our primary analyses using fixed‐effect meta‐analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [1.05, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.5 Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.95, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.6 Re‐categorising financial conflicts of interest into financial conflicts of interest related to any for‐profit company <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.35, 23.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analyses for narrative reviews</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000040.pub3/references#MR000040-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.MR000040.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#MR000040-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#MR000040-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#MR000040-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#MR000040-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="pt#MR000040-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="ru#MR000040-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#MR000040-note-0002">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000040\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000040\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000040\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000040\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000040\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000040.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000040.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.MR000040.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.MR000040.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000040.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717609143"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000040.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717609147"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000040.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbc11aae39371',t:'MTc0MDcxNzYxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 